Alar Pharmaceuticals (Taiwan) Insiders
6785 Stock | TWD 151.50 0.50 0.33% |
Recap of Alar Pharmaceuticals' management performance can provide insight into the venture performance.
Alar |
Symbol | 6785 |
Name | Alar Pharmaceuticals |
Type | Stock |
Country | Taiwan |
Exchange | TWO |
Information on Alar Pharmaceuticals Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Thematic Opportunities
Explore Investment Opportunities
Alar Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (10.09) % which means that it has lost $10.09 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (10.38) %, meaning that it generated substantial loss on money invested by shareholders. Alar Pharmaceuticals' management efficiency ratios could be used to measure how well Alar Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Alar Pharmaceuticals Workforce Comparison
Alar Pharmaceuticals is rated fourth in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 91.0. Alar Pharmaceuticals totals roughly 19.0 in number of employees claiming about 21% of equities under Drug Manufacturers—Specialty & Generic industry.
Alar Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Alar Pharmaceuticals Price Series Summation is a cross summation of Alar Pharmaceuticals price series and its benchmark/peer.
About Alar Pharmaceuticals Management Performance
The success or failure of an entity such as Alar Pharmaceuticals often depends on how effective the management is. Alar Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Alar management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Alar management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Alar Pharmaceuticals Inc. operates as a drug development company. The company was founded in 2016 and is based in Taichung, Taiwan. ALAR PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 19 people.
Please note, the imprecision that can be found in Alar Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Alar Pharmaceuticals. Check Alar Pharmaceuticals' Beneish M Score to see the likelihood of Alar Pharmaceuticals' management manipulating its earnings.
Additional Tools for Alar Stock Analysis
When running Alar Pharmaceuticals' price analysis, check to measure Alar Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alar Pharmaceuticals is operating at the current time. Most of Alar Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alar Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alar Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alar Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.